Tag: AccurKardia
Accurkardia granted patent for AI-driven ECG detection of cardiac amyloidosis
Accurkardia has announced that it has been granted US patent number 12,620,488 for the company's proprietary machine learning-based system for identifying cardiac amyloidosis from...
Accurkardia launches AccurECG 2.0 following US FDA 510(k) clearance
Accurkardia has announced US Food and Drug Administration (FDA) 510(k) clearance and the commercial launch of its AccurECG analysis system (v2.0). AccurECG 2.0 builds...
AccurKardia announces clinical pilot study of ECG-based, AI-powered hyperkalaemia detection software
AccurKardia has announced the initiation of a multicentre clinical pilot study of AK+ Guard—a US Food and Drug Administration (FDA) Breakthrough Device designated, artificial...
HeartBeam’s synthesised 12-lead ECG meets clinical endpoints in VALID-ECG study
HeartBeam has announced that its “groundbreaking” synthesised 12-lead electrocardiogram (ECG) successfully met the clinical endpoints in the VALID-ECG pivotal study. Thomas Deering (Piedmont Heart...